NEW YORK, NY / ACCESS Newswire / August 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GSK plc ("GSK plc") (NYSE:GSK) concerning possible violations of federal securities laws. GSK issued a press release on July 17, 2025, announcing "that the US Food and Drug Administration (FDA) Oncologic Drugs […]
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fluor Corporation ("Fluor Corporation") (NYSE:FLR) concerning possible violations of federal securities laws. On August 1, 2025, Fluor reported quarterly earnings below expectations with revenue adjusted earnings of 43 cents per share on
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=160599&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=160602&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Anika Therapeutics, Inc. ("Anika Therapeutics, Inc.") (NASDAQ:ANIK) concerning possible violations of federal securities laws. Anika issued a press release on July 30, 2025, "announc[ing] topline results from its U.S. pivotal clinical trial
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc.") (NYSE:INSP) concerning possible violations of federal securities laws. On August 5, 2025, Inspire issued a press release announcing better-than-expected second quarter fiscal 2025 results,
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Praxis Precision Medicines, Inc. ("Praxis Precision Medicines, Inc.") (NASDAQ:PRAX) concerning possible violations of federal securities laws. Praxis Precision Medicines, Inc. issued a press release on August 4, 2025, announcing its financial results
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=160604&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exelixis, Inc. ("Exelixis, Inc.") (NASDAQ:EXEL) concerning possible violations of federal securities laws. Exelixis issued a press release on July 28, 2025, "report[ing] financial results for the second quarter of 2025" and "provid[ing]
NEW YORK, NY / ACCESS Newswire / August 9, 2025 / If you suffered a loss on your Biohaven Ltd. (NYSE:BHVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biohaven-ltd-lawsuit-submission-form?prid=160609&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call